Related Experiment Video

Updated: Jun 21, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians

Hong-wei Tan, Xin-hua Wang, Hai-feng Shi

    International Journal of Cardiology
    |July 21, 2009
    PubMed

    Insights

    Catheter ablation for atrial fibrillation (AF) is safe and effective in octogenarians. Outcomes in patients aged 80 and over are comparable to younger individuals, with a lower need for repeat procedures.

    Area of Science:

    • Cardiology
    • Electrophysiology
    • Geriatric Medicine

    Background:

    • Atrial fibrillation (AF) is a common arrhythmia.
    • Catheter ablation is an established treatment for AF.
    • Octogenarians represent an understudied population for AF ablation.

    Purpose of the Study:

    • To assess the safety and efficacy of catheter ablation for AF in octogenarians.
    • To compare outcomes in octogenarians versus younger patient groups.

    Main Methods:

    • Retrospective analysis of 377 consecutive AF patients undergoing catheter ablation.
    • Patients stratified into three age groups: ≥80 (Group 1), 70-79 (Group 2), and 60-69 (Group 3).
    • Efficacy, safety, and complication rates were evaluated over an 18-month follow-up.

    Main Results:

    • Similar success rates after one procedure across all age groups (70% in Group 1, 72% in Group 2, 74% in Group 3).
    • Comparable major complication rates among the groups.
    • Octogenarians had a lower likelihood of requiring repeat procedures (8%) compared to younger groups (15-18%).

    Conclusions:

    • Catheter ablation is a safe and effective treatment option for atrial fibrillation in octogenarians.
    • Outcomes in octogenarians are comparable to those in younger patients, with added benefits of fewer repeat procedures.
    Abstract

    More Related Videos

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

    Published on: May 26, 2015

    Robotic Ablation of Atrial Fibrillation11:21

    Robotic Ablation of Atrial Fibrillation

    Published on: May 29, 2015

    Related Concept Videos

    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Pharmacodynamics in Geriatric Patients: Effects of Age01:27

    Pharmacodynamics in Geriatric Patients: Effects of Age

    Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
    Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

    Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

    Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

    Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...